Evidence map›Paper›PMID 24751825›Full record

ArticlePloS one2014

Hygromycin B and apramycin antibiotic resistance cassettes for use in Campylobacter jejuni.

Andrew Cameron, Erin C Gaynor

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. FlagellinMicrobiology (Reading, England) · 2023
    Article
  8. MultipleFrontiers in microbiology · 2023
    Article
  9. Cysteine Biosynthesis inBiomolecules · 2022
    Article
  10. Article
  11. Role ofInfection and immunity · 2020
    Article
  12. Article
  13. Article
  14. Article
  15. Identification of aFrontiers in microbiology · 2019
    Article
  16. Article
  17. Phase-Variable Changes in the Position ofJournal of bacteriology · 2017
    Article
  18. The Periplasmic Chaperone Network ofFrontiers in microbiology · 2017
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Andrew CameronDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
Erin C GaynorDepartment of Microbiology and Immunology, University of British Columbia, Vancouver, British Columbia, Canada.
University of British Columbia · CA

Funding

Canadian Institutes of Health Research MOP-68981
6 · The paper itself

Abstract

Campylobacter jejuni genetic manipulation is restricted by the limited number of antibiotic resistance cassettes available for use in this diarrheal pathogen. In this study, two antibiotic resistance cassettes were developed, encoding for hygromycin B and apramycin resistance, for use in mutagenesis or for selection of gene expression and complementation constructs in C. jejuni. First, the marker genes were successfully modified to allow for insertional mutagenesis or deletion of a gene-of-interest, and were bracketed with restriction sites for the facilitation of site-specific cloning. These hygromycin B and apramycin markers are encoded by plasmids pAC1H and pAC1A, respectively. We also modified an insertional gene-delivery vector to create pRRH and pRRA, containing the hygromycin B and apramycin resistance genes, and 3 unique restriction sites for the directional introduction of genes into the conserved multi-copy rRNA gene clusters of the C. jejuni chromosome. We determined the effective antibiotic concentrations required for selection, and established that no harmful effects or fitness costs were associated with carrying hygromycin B or apramycin resistance under standard C. jejuni laboratory conditions. Using these markers, the arylsulfatase reporter gene astA was deleted, and the ability to genetically complement the astA deletion using pRRH and pRRA for astA gene insertion was demonstrated. Furthermore, the relative levels of expression from the endogenous astA promoter were compared to that of polycistronic mRNA expression from the constitutive promoter upstream of the resistance gene. The development of additional antibiotic resistance cassettes for use in Campylobacter will enable multiple gene deletion and expression combinations as well as more in-depth study of multi-gene systems important for the survival and pathogenesis of this important bacterium.

Indexed as

ArylsulfatasesCampylobacter jejuniDrug Resistance, MicrobialGene DeletionGenes, BacterialGenetic Complementation TestGenetic VectorsGene Transfer TechniquesHygromycin BMutagenesis, InsertionalNebramycinapramycinArylsulfatasesHygromycin BNebramycin

Identifiers

PMID24751825
PMCPMC3994027
OpenAlexW2074014006

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.